Coherus Oncology, Inc. (CHRS)
NASDAQ·Healthcare·Biotechnology
$1.77
-3.80%
Mkt Cap $215.55M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 9, 2026 | $13.91M | $12.75M | -8.37% | -$0.36 | -$0.34 | +4.25% | — | — |
| Q4 2025 Nov 6, 2025 | $14.09M | $11.57M | -17.86% | -$0.32 | -$0.33 | -3.13% | — | — |
| Q3 2025 Aug 7, 2025 | $11.99M | $10.25M | -14.45% | -$0.31 | -$0.34 | -9.68% | — | — |
| Q2 2025 May 12, 2025 | $60.96M | $7.60M | -87.54% | -$0.31 | -$0.35 | -12.90% | — | — |
| Q1 2025 Mar 10, 2025 | $60.00M | $54.14M | -9.76% | -$0.10 | -$0.28 | -180.00% | — | — |
| Q4 2024 Nov 6, 2024 | $43.88M | $70.77M | +61.30% | -$0.10 | -$0.01 | +90.00% | — | — |
| Q3 2024 Aug 8, 2024 | $61.37M | $64.98M | +5.88% | -$0.21 | -$0.14 | +33.33% | — | — |
| Q2 2024 May 9, 2024 | $80.25M | $77.06M | -3.97% | -$0.05 | -$0.32 | -540.00% | — | — |
| Q1 2024 Mar 13, 2024 | $96.40M | $91.52M | -5.06% | -$0.21 | -$0.62 | -195.24% | — | — |
| Q4 2023 Nov 6, 2023 | $88.24M | $74.57M | -15.49% | -$0.21 | -$0.27 | -28.57% | — | — |
| Q3 2023 Aug 2, 2023 | $82.24M | $58.72M | -28.60% | -$0.52 | -$0.38 | +26.92% | — | — |
| Q2 2023 May 8, 2023 | $47.44M | $32.44M | -31.63% | -$0.61 | -$0.75 | -22.95% | — | — |
| Q1 2023 Mar 6, 2023 | $47.69M | $45.35M | -4.90% | -$0.64 | -$0.60 | +6.25% | — | — |
| Q4 2022 Nov 8, 2022 | $56.69M | $45.42M | -19.88% | -$0.53 | -$0.96 | -81.13% | — | — |
| Q3 2022 Aug 4, 2022 | $62.04M | $60.15M | -3.04% | -$0.96 | -$0.65 | +32.29% | — | — |
| Q2 2022 May 5, 2022 | $69.54M | $60.12M | -13.56% | -$0.80 | -$1.24 | -55.00% | — | — |
| Q1 2022 Feb 17, 2022 | $82.61M | $73.37M | -11.18% | -$0.61 | -$0.60 | +1.64% | — | — |
| Q4 2021 Nov 8, 2021 | $61.88M | $82.50M | +33.33% | -$0.40 | -$0.49 | -22.50% | — | — |
| Q3 2021 Aug 5, 2021 | $88.18M | $87.64M | -0.61% | -$0.25 | -$0.40 | -60.00% | — | — |
| Q2 2021 May 6, 2021 | $99.57M | $83.03M | -16.61% | $0.09 | -$2.37 | -2733.33% | — | — |